Applying a small mechanical force to embryonic stem cells could be a new way of coaxing them into a specific direction of differentiation, researchers at the University of Illinois report. Applications for force-directed cell differentiation include therapeutic cloning and regenerative medicine.
IRVINE, Calif.—-California Stem Cell, Inc. and Families of Spinal Muscular Atrophy announced today that they have completed a formal pre-Investigational New Drug meeting with the Food and Drug Administration for guidance on the clinical and regulatory pathway and requirements for submission of an IND to initiate human trials for a stem cell-derived motor neuron replacement therapy for Spinal …
RALEIGH, N.C., Oct. 12, 2009 (GLOBE NEWSWIRE) — DARA BioSciences, Inc. (Nasdaq: DARA ), a development-stage biopharmaceutical company, announced today that the Company has entered into an Addendum and First Amendment to Material Transfer Agreement …
Researchers at UCSF Medical Center have begun enrollment for an early-stage clinical trial to evaluate the safety and efficacy of an adult stem cell therapy for patients who have just experienced their first acute myocardial infarction, or heart attack.
The US Food and Drug Administration (FDA) said the first clinical trial to test a new stem cell treatment for the fatal neurodegenerative disease ALS (amyotrophic lateral sclerosis) this month (ALS) can go ahead.
Hi everyone, unfortunately I have some bad news. Last week we experience a database corruption and lost most of our articles from mid August to now. The latest backup I have is from August 13th 2009. I will try to bring that backup online on Tuesday. Please bear with me until [...]
Intellectual property surrounding stem cell modulators, and belonging both to Children’s Hospital Boston and Massachusetts General Hospital, has been granted exclusively to Fate Therapeutics Inc., a La Jolla, Calif.-based biotech that houses some of its research in the Boston area.
BioTime, a biotechnology company, has reported that the California Institute for Regenerative Medicine, or CIRM, has approved a grant to the company of $4.7m to fund research related to its ACTCellerate embryonic stem cell technology. The overall …
TORONTO — Scientists have made a breakthrough involving a method that turns stem cells a fluorescent green colour for study in the laboratory, which is like having a “spotlight” to help differentiate them from other cells. They’ve managed to get the …
Sen. Mike Folmer has jumped into the stem-cell debate. Folmer, a Republican whose district includes Lebanon County, wants to create a public blood bank for the collection of umbilical-cord and placenta blood to be used for the treatment of metabolic …